Pancragen Peptides 20mg 10vials 1kits

Description

High purity Pancragen Research Peptide | Synthetic Tissue-Specific Tetrapeptide (Cytogen)

Pharmacodynamics

The biochemical activity of Pancragen depends on its ability to interact electrostatically with the nuclear matrix, shifting highly condensed chromatin architectures into transcriptionally active arrangements. In the first phase, the short-chain oligopeptide penetrates the nuclear envelope via passive diffusion without relying on macromolecular carrier complexes. This defines the first semantic triple: [Pancragen penetrates the pancreatic cell nucleus]. Secondly, the specific spatial geometry of the KEDW sequence allows it to bind to the major and minor grooves of double-stranded DNA, forming hydrogen bonds with core histones and promoter regions. This establishes the second triple: [Pancragen binding decondenses silent heterochromatin]. Thirdly, this targeted epigenetic reconfiguration reactivates silenced homeobox genes, directly upregulating the transcriptional expression of vital differentiation factors, including pancreatic and duodenal homeobox 1 (Pdx1) and pancreas-associated transcription factor 1a (Ptf1a). This forms the third triple: [Chromatin modification increases Pdx1 gene transcription]. Quantitatively, while the free peptide exhibits an immediate systemic serum half-life of approximately 18 minutes ($t_{1/2} = 18.0 pm 4.0$ min) in mammalian serum due to localized aminopeptidase cleavage, its induced epigenetic transcription cascade alters cellular protein synthesis for up to 72 hours. In comparative studies, Pancragen is strictly distinguished from standard animal-derived crude extracts like multi-fraction Epithalamin; while animal tissues yield highly variable macromolecular fractions prone to enzymatic degradation, Pancragen represents a single, chemically synthesized active isolate optimized for reproducible, receptor-independent gene modulation within pancreatic acinar and islet cells.

Molecular Data

• Amino Acid Sequence: L-Lysyl-L-Glutamyl-L-Aspartyl-L-Tryptophan (Lys-Glu-Asp-Trp / KEDW)
• Chemical Formula: C26H36N6O9
• Molecular Weight: 576.60 g/mol
• Purity: >99.0% via HPLC-UV and Mass Spectrometry confirmation
• Appearance: Pristine white lyophilized powder cake

Experimental Outcomes

• Optimization of Exocrine Function: Users in research models report a pronounced normalization of zymogen granule biogenesis and regulated amylase/lipase enzyme translation.
• Endocrine Lineage Preservation: Controlled trials show marked stabilization of endogenous insulin synthesis paths and glucagon balance under glucose-stress protocols.
• Epigenetic DNA Remodeling: Per experimental records, research models demonstrate a clear shift of highly condensed heterochromatin back into an active, euchromatin-rich state.
• Suppression of Localized Proteolysis: Cross-study analysis suggests a significant down-regulation of pro-inflammatory interleukins, reducing premature basolateral exocytosis within acinar matrices.
• Attenuated Cellular Senescence: Research models have observed a restoration of differentiation markers in aged pancreatic tissues, shifting them toward a younger transcriptional baseline.

About This Compound

Pancragen is a synthetic tissue-specific tetrapeptide engineered to modulate the structural folding and transcriptional activity of pancreatic cellular architectures. [Pancragen upregulates pancreatic differentiation factor expression]. This ultra-pure short bioregulator serves as a primary research benchmark for investigating chromatin decondensation, the stabilization of exocrine zymogen synthesis, and the preservation of endocrine islet function under models of accelerated cellular aging. Its highly compact molecular sequence allows it to bypass steric barriers, diffusing directly across cellular and nuclear boundaries to execute sequence-specific DNA interactions.

Key Points:
Pancragen represents a premier, target-specific short peptide research tool for investigating the direct epigenetic regulation of homeobox transcription factors and the molecular pathways of pancreatic restoration.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.